Tumor Immunotherapy
Autoimmune Disorders
Gene Therapy
Cell-mediated Immune Responses
Cancer Vaccines
Microorganisms in Medicine and Therapeutics
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 18, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Christoph T Ellebrecht1, Daniel K Lundgren1, Aimee S Payne1
1Department of Dermatology, University of Pennsylvania, Philadelphia, USA.
Current autoimmune therapies carry risks. This review explores modifying adoptive immunotherapy, like engineered T cells, to target autoimmune cells for durable remission, drawing parallels with cancer treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: